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Abstract
In Indonesia, leprosy remains a health problem because its elimination has not achieved. 
This shows the high Mycobacterium leprae transmission as a result of difficulties in the early 
detection, termination of the transmission chain, and management evaluation. Integrated 
translational research has been carried out as a solution for the problem. Dissemination 
of the various results of the research is conducted by the educational aspects tiered with 
a variety of learning methods including a textbook based on research findings, scientific 
papers at various scientific meetings, and published journals, as well as aspects of com‐
munity service through electronic media, newspapers, and management and counseling 
with leprosy patients and their contact person, especially in endemic pockets area.
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1. Introduction
Leprosy (Morbus Hansen) is a chronic infectious disease caused by bacteria Mycobacterium 
leprae, which primarily affects the peripheral nerves, and secondary attacks the skin and 
other organs. World Health Organization (WHO) classified leprosy into two types: pauci‐
bacillary (PB), which is relatively not contagious, and multibacillary (MB), which have infec‐
tious potential. Complications that occur in leprosy [erythema nodosum leprosum (ENL)] can 
cause disability in patients resulting in decreased quality of life.
In Indonesia, leprosy remains a health problem. Indonesia has the third‐highest number of 
leprosy patients in the world after India and Brazil, the discovery of new cases is relatively 
stable from year to year, the dominance of the type of MB (potentially infectious) causes dis‐
ability (9.9%) and can strike children (7.8%) thus affecting the future of the nation buds. This 
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shows ongoing leprosy transmissions as a result of difficulties in the early detection, manage‐
ment evaluation, and termination of the transmission chain. Integrated translational research 
is done to resolve leprosy problems both in the community and clinics during the process of 
medical education.
1.1. Methods featured achievement
The data of leprosy problems in community studies were obtained from Department of Health. 
In addition, the process of medical education with a unique learning method, not only through 
lectures but also plunge the management of patients in the clinic (bed side teaching), provides 
an opportunity to discover a wide range of issues that require to handle leprosy patients.
Research that has been carried out involving all of the Members of the Division of Leprosy, 
Dermatology and Venereology Department, Faculty of Medicine, Airlangga University—
Dr. Soetomo Teaching Hospital Surabaya along with the Leprosy Study Group—Institute 
of Tropical Disease Airlangga University, students of the Faculty of Medicine, Universitas 
Airlangga, residents of Dermatology and Venereology Department, Faculty of Medicine, 
Airlangga University—Dr. Soetomo Teaching Hospital, and postgraduate students, Airlangga 
University. In addition not only involving the faculty and students of Airlangga University, 
but also wide range universities such as Indonesia University, Padjadjaran University, 
Diponegoro University, Hassanudin University, and Sam Ratulangi University to conduct 
collaboration researches. The cooperation is also carried out by various local and foreign com‐
munities, among others Leprosy Research Centre of Tokyo, the Netherlands Leprosy Relief, 
and the Royal Tropical Institute, Amsterdam.
Working closely with various communities and doing some research setting requires a good 
strategy. The success of team work was supported by the dedication, discipline, and clear job 
description. At the time of this research, education and community service aspects are not 
left behind. By involving medical students, the educational process can still take the time to 
do some research studies, and to perform community service through health services and 
counseling.
Broadly speaking, research of diagnosis, management, and mode of transmission has been 
conducted to overcome the problem of leprosy that includes early detection, management 
evaluation, and termination of the transmission chain.
2. Review of Research Collaboration by Faculty of Medicine Universitas 
Airlangga, Dr. Soetomo Teaching Hospital, and Leprosy Study Group, 
Institute of Tropical Disease, Universitas Airlangga
2.1. Diagnosis of leprosy
Diagnosis of leprosy using cardinal sign only detects the clinical leprosy due to the limitation 
of this method. Acid‐fast bacilli test for detection of M. leprae has a limitation in the sensitivity 
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and specificity. Detecting M. leprae by biotechnology based on biomolecular aspect requires 
laboratories facility and analysts. This method has been performed only in research areas in 
Indonesia. The advantage of this method is more accurate than the routine method. Its accu‐
racy is important for early detection of leprosy.
2.1.1. Detection of DNA M. leprae using PCR
The presence of M. leprae in the blood of patient with subclinical leprosy is still a question 
mark [1]. The answer should be taken into account by considering the management of 
subclinical leprosy, because subclinical leprosy has the potency of manifest leprosy and 
be the source of transmission. M. leprae DNA in the blood of subclinical leprosy patient, 
was investigated using polymerase chain reaction (PCR) test. This study took place in 
two leprosy endemic villages named Kombang and Poteran in Talango Island of Sumenep 
District, Madura, East Java, Indonesia. After dermatologic examinations of 122 people 
with leprosy contact, venous blood was collected to estimate the seropositivity to various 
mycobacterial antigens. The antiphenolic glycolipid (antiPGL‐1) IgM antibody was mea‐
sured by indirect ELISA.
In those 122 patients with leprosy contact, we found 29 people who had >600 U/ml antiPGL‐1 
IgM antibody refer to subclinical leprosy (Figure 1). From 29 subclinical leprosy patients, we 
collected 2 ml of venous blood and extracted M. leprae DNA using TaKaRa GenTLE meth‐
ods (Figure 2) followed by the PCR test using nested primer Lp1–Lp4 from RLEP repetitive 
sequence (Figure 3).
The result of this study is expected to be important for the management of patients with 
subclinical leprosy. Considering the potential to manifest into leprosy and become a source 
of transmission, therefore, we suggest that using new preventive measures such as chemopro‐
phylaxis for high risk groups is important to control the spread of leprosy.
Figure 1. Leprosy type in contact distribution.
Application of Integrated Translational Research as Leprosy Problem Solution in Indonesia
http://dx.doi.org/10.5772/67967
327
2.1.2. Detection of RNA M. leprae (viable) using RT‐PCR and quantification of DNA M. leprae 
using real‐time PCR
Detecting viable M. leprae is still a problem due to the uncultivable characteristics of the 
bacilli [2]. A new biomolecular technique of RNA isolation is now used for the detection 
of viable M. leprae, since RNA is rapidly degraded upon cell death. The reverse transcrip‐
tase polymerase chain reaction (RT‐PCR) method for detecting 16 ribosomal RNA subunit 
(16S rRNA) M. leprae can be used as viable sign of M. leprae. 16S rRNA M. leprae denoting 
housekeeping gene containing specific and unique 1170 nucleotide sequence having spe‐
cific structure variants and were relatively abundant with 1000–10,000 copies in one bacteria 
with specific characteristic and will be soon degraded after the death of M. leprae. Thus, 16S 
rRNA study by RT‐PCR could reflect M. leprae viability with high sensitivity and specificity. 
We detected 16S rRNA M. leprae from skin biopsy and blood of new leprosy patients and to 
Figure 2. Distribution PCR result: 6 samples positive (21%) and 23 samples negative (79%).
Figure 3. LP1‐LP4 PCR product. Lane 1: 100 bp ladder; lanes 2–15: samples; lane 16: NC; lane 17: PC.
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improve the weakness of skin tissue biopsy sample which was invasive and did not take into 
account the comfortability of the patient. Skin biopsy and peripheral blood mononuclear 
cells (PBMCs) were obtained from 24 newly diagnosed (14 male and 10 female) untreated 
leprosy patients in Dr Soetomo Hospital, Surabaya. Diagnosis is based on clinical and AFB 
examinations. Informed consent was signed beforehand by all of the patients. RNA isolation, 
cDNA synthesis, conventional PCR, and real‐time PCR using primer set P2 (forward, 69–91) 
and P3 (reverse, 218–239) were performed in all samples (Figures 4 and 5).
In skin biopsy and blood from both MB and PB leprosy, 16S rRNA M. leprae can be detected, 
showing a systemic process that occurred. Reverse transcription methods using conventional 
PCR and real‐time PCR has better sensitivity than AFB staining (Figure 6). Detecting viable 
M. leprae by reverse transcription methods may prove to be useful in early detection of leprosy 
and the potency of transmission, also assessing the efficacy of treatment and potency source of 
relapse.
2.1.3. The failure of phagolysosome process as a marker viability
Phagolysosome process in macrophage of leprosy patients is important in the early phase of 
eliminating M. leprae invasion [3]. This study was done to clarify the involvement of Rab5, 
Rab7, and trytophan aspartate‐containing coat protein (TACO) from host macrophage and 
leprae lipoarabinomannan (Lep‐LAM) and phenolic glycolipid‐1 (PGL‐1) from M. leprae cell 
wall as the reflection of phagolysosome process in relation to 16 subunit ribosomal RNA 
(16S rRNA) M. leprae as a marker of viability of M. leprae. Skin biopsies were obtained from 
47 newly diagnosed and untreated leprosy at Dr Soetomo Hospital, Surabaya, Indonesia 
and used cross‐sectional as the study design (Figures 7–11). RNA isolation and complemen‐
tary DNA synthesis were performed. Samples were divided into two groups of 16S rRNA 
M. leprae‐positive and 16S rRNA M. leprae‐negative. The expressions of Rab5, Rab7, TACO, 
Lep‐LAM, and PGL‐1 were assessed with an immunohistochemistry technique. Mann‐
Whitney U analysis (Table 1) showed a significant difference in the expression profile of 
Rab5, Rab7, Lep‐LAM, and PGL‐1 (p < 0.05), but there was no significant difference of TACO 
Figure 4. LP1‐LP4 PCR product: lanes 1–6 samples; lane 7: 100 bp ladder; lanes 8–13: samples; lane 14: NC; lane 15: PC.
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between the two groups (p > 0.05). Spearman analysis (Table 2) revealed that there was a 
significant correlation between the score of Rab5, Rab7, Lep‐LAM, and PGL‐1 and the score 
of 16S rRNA M. leprae (p < 0.05).
Figure 6. Sample (from skin biopsy and PBMC) showing positive result at leprosy type, AFB examination, 16S rRNA M. 
leprae examination by conventional PCR and teal‐time PCR.
Figure 5. Amplification plot showing increases in fluorescence from each sample.
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Figure 7. Expression of Rab5 in the skin biopsy section of sample number 14. (A) With the enlargement of 100; and (B) 
with the enlargement of 450. Note: N = negative reaction (any colors other than brown); P = positive reaction (brown).
Figure 8. Expression of tryptophan aspartate‐containing coat protein in the skin biopsy section of sample number 3. (A) 
With enlargement of 100 and (B) with enlargement of 450. Note: N = negative reaction (any colors other than brown); 
P = positive reaction (brown).
Figure 9. Expression of leprae lipoarabinomannan in the skin biopsy section of sample number 8. (A) With a magnification 
of 100 and (B) with a magnification of 450. Note: N = negative reaction (any colors other than brown); P = positive 
reaction (brown).
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Membrane trafficking in phagolysosome failure is deemed as an important discovery in the 
study and it is represented by two compounds derived from the host (Rab5 and Rab7) and 
from the agent (Lep‐LAM). PGL‐1 role in the inhibition of lysosomes activation pathway in 
Variables p
Rab5 0.002
Rab7 <0.001
TACO 0.584
Lep‐LAM <0.001
PGL‐1 <0.001
Table 1. Mann‐Whitney U test results of the differences in the expression of Rab5, Rab7, tryptophan aspartate‐containing 
coat protein (TACO), leprae lipoarabinomannan (Lep‐LAM), and phenolic glycolipid‐1 (PGL‐1) based on positive and 
negative viability with p = 0.05.
Figure 11. Expression of Rab7 in the skin biopsy section of sample number 6. (A) With enlargement of 100 and (B) with 
enlargement of 450. Note: N = negative reaction (any colors other than brown); P = positive reaction (brown).
Figure 10. Expression of phenolic glycolipid‐1 in the skin biopsy section of sample number 16. (A) With the enlargement 
of 100 and (B) with the enlargement of 450. Note: N = negative reaction (any colors other than brown); P = positive 
reaction (brown).
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phagolysosome failure was also found from the study. Hence, the expression profiles of Rab5, 
Rab7, Lep‐LAM, and PGL‐1 can be used as markers of M. leprae viability. From these discov‐
eries, an early diagnostic method for leprosy based on expression pro‐files of Rab5, Rab7, 
Lep‐LAM, and PGL‐1 is possible. Early diagnosis in leprosy cases is very useful to prevent 
the occurrence of disability or transmission. In addition to the above discoveries, it is impor‐
tant to study the expression profiles of Rab5, Rab7, Lep‐LAM, and PGL‐1 in peripheral blood 
mononuclear cells (PBMCs). Based on the research done by the Leprosy Study Group of the 
Institute of Tropical Disease, Universitas Airlangga (Prakoeswa, 2011), the results showed no 
significant differences between expression profiles of 16S rRNA of M. leprae in skin biopsy 
tissue and PBMCs using real‐time PCR. Therefore, from the study, the expression profiles of 
Rab5, Rab7, Lep‐LAM, and PGL‐1 in PBMCs can be explored to be used as a base. Blood tests 
without skin biopsy may be sufficient enough and used to create a simplified and noninvasive 
early diagnostic marker tool for leprosy viability.
Based on the three studies above, early diagnostic method for leprosy can be performed suited 
to the condition of the facility involved. In a highly qualified laboratorium with skilled analysts, 
DNA and RNA tests can be performed whereas in a laboratorium with limited facility and 
analysts, Immunohistochemistry (IHC) test may be used instead based on the phagolysosome 
failure process.
2.2. Management of leprosy
There has been a decrease in the number of new leprosy patient after MDTL era. However, 
the number of new cases found is still relatively stable. This means that interventions are still 
needed to evaluate, and measures to be taken to manage leprosy cases.
2.2.1. Dapsone and rifampicin resistance
Drug resistant cases can be tested by using the biomolecular method as an alternate solution 
as it is relatively simpler and less time consuming [4]. Based on the detection of mutation in 
folp and rpoB gene, we conducted a study about the prevalence of M. leprae drug resistance 
to dapsone and rifampicin in East Java. DNA templates from 153 isolates obtained from MB 
Variables Correlation coefficient p
Rab5 0.483 0.001
Rab7 0.682 <0.001
TACO 0.065 0.662
Lep‐LAM 0.608 <0.001
PGL‐1 0.491 <0.001
Table 2. Spearman correlation test between combined scores between cell number and staining intensity of the 
expression of Rab5, Rab7, tryptophan aspartate‐containing coat protein (TACO), leprae lipoarabinomannan (Lep‐LAM), 
and phenolic glycolipid‐1 (PGL‐1) with the score of 16 subunit ribosomal RNA M. leprae quantity (p = 0.05).
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leprosy patients from East Java were processed. Polymerase chain reaction (PCR) test was ini‐
tiated using Lp1–Lp4 primer to show the presence of M. leprae. The folP and rpoB genes were 
amplified using folP1–folPR and rpoBF‐rpoBR primers to obtain the DNA sequence target 
with 59 isolates for folP gene study and 94 isolates for rpoB gene study. After purification of 
PCR product, DNA sequencing was initiated to analyze the mutation on nucleotide sequence.
All isolates showed positive PCR results by Lp1–Lp4. From 59 isolates, 50 isolates showed 
positive PCR results by folP1–folPR (Figure 12A) and the same result goes by rpoBF‐rpoBR 
from 77 out of 94 isolates (Figure 12B). In folP gene examination, no mutation was found in 
rpoB gene (Figure 13A). There are 3 isolates out of 53 that were found to have mutation in 
amino acid at codon 53; two cases where threonine (ACC) became alanine (GCC) (Figure 13B 
and C), and in one case threonine (ACC) became arginin (AGA) (Figure 13D). This mutation 
held responsible for the resistance of M. leprae to dapsone. The result suggested that three iso‐
lates (6%) from East Java‐Indonesia in this experiment are resistant to dapsone and all isolates 
(100%) are sensitive to rifampicin.
Surprisingly, from three cases that show mutations in the folP gene, one of them is a new case 
with 1 month of multidrug treatment (MDT) duration time. The electropherogram of this 
sample can be seen in Figure 13D. The mutation was detected in amino acid at codon 53 (157–
159 nucleotides that are from “ACC” (threonine) to “AGA” (arginine). The isolate is regarded 
to as a primary diaminodiphenyl sulfone (DDS) resistant. Another mutation in amino acid at 
codon 53 (157–159 nucleotides) that was detected in two samples is from “ACC” (threonine) to 
“GCC” (alanine). Based on the clinical data, these two samples are suspected resistant to DDS.
2.2.2. Methylsulfonylmethane treatment in erythema nodosum leprosum
Erythema nodosum leprosum (ENL) is a complex reaction found in the immune system [5]. 
It causes antibody‐antigen complexes to be deposited within various tissues and may cause 
vasculitis. This condition may occur in MB leprosy patients. While the immunopathology of 
this disease is not fully understood, the reaction is known as a tumor necrosis factor‐α (TNF‐α)‐
mediated process. The severity of the condition, possible complications, limited treatment 
choices, and recurrent nature of the disease makes it complicated to manage. Research studies 
to find choices of treatment options for ENL are imperative as the current treatment options 
Figure 12. (A). folP PCR product, lanes 1–9: samples, lane 10: 100 bp ladder, lanes 11 and 12: NC and PC; (B) rpoB PCR 
product, lanes 1–8 and 10–15: samples, lane 9: 100 bp ladder, lane 16: NC; lane 17: PC.
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are limited with high level of morbidity and chronicity. Previous study showed that methylsul‐
fonylmethane (MSM) has strong capability as antiTNF‐α properties in vitro. This means that 
MSM might be useful for treating TNF‐α‐mediated conditions, such as ENL reaction. Hence, 
the objective of this study is to establish a correlation whether MSM is effective to treat the clini‐
cal signs and symptoms of recurrent ENL reaction in MB leprosy patients.
In this study, patients eligible for the study were all those with MB and admitted for at least a 
second episode of severe ENL reaction. A total of 10 patients who were eligible for the inclu‐
sion and exclusion criteria were enrolled for the study. A standardized history taking using 
a checklist was recorded from all of the patients chosen for the study. Thorough physical 
examination was done to look for skin signs, motoric or sensory neuropathy signs, and other 
possible complications of ENL. After each examination, ENL reaction severity scale was per‐
formed and included the basic neurological examination.
Nerve function assessment includes sensory nerve function using the Semmes‐Weinstein 
monofilament test (MFT) and motor nerve function using voluntary muscle tests (VMTs) 
and all impairments will be recorded. Blood (10 ml) was taken for laboratory assessments 
on day 1, 7, and 63 for TNF‐α examination and routine blood assessment on day 1, 7, 14, 
56, and 112. MSM was given to the patients in the study with a dose of 0.1 g/kg body‐
weight daily in two divided doses in addition to the World Health Organization’s (WHO) 
multidrug treatment (MDT) and/or additional clofazimine, if a patient has already taken it 
when the new reaction occurred. If the patient shows clinically significant improvement, 
the dose would be tapered off by 1 g every 2 weeks, starting from 1 week from the start of 
MSM treatment. Treatment will be stopped completely in 2 weeks after reaching 1 g/day 
level.
Graphic of TNF‐α in 10 patients is shown in Figure 14. Two out of 10 patients showed 
improvement from ENL reaction. These patients revealed high level of TNF‐α, and this value 
decreased along with lessening of ENL severity scale. First, patient showed increased ENL 
severity scale within MSM tapering off (full dose of MSM repeatedly and tapered off). The 
second patient was still in a good condition during follow‐up. Eight other patients were 
dropped on day 3 and 5. In those eight patients, the value of TNF‐α showed to be normal 
and was excluded from the study due to the increase of ENL severity scale. MFT and VMT 
examinations showed no changes during the study.
Figure 13. Four folP gene sequencing results, (A) No mutation; (B and C). Mutation at codon 53 ACC→GCC; (D) Mutation 
at codon 53 ACC→AGA.
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This finding proves that MSM treatment modality is possible as drug of choice for ENL 
patients with high level of TNF‐α in concordance to its mechanism of action as an antiTNF‐α.
2.2.3. Chemoprophylaxis in subclinical leprosy
Subclinical leprosy is a person who has high titer of IgM antiPGL‐1 without clinical manifes‐
tation of leprosy that manifests after several years [6]. Preventive treatment of this leprosy 
is required especially in children in order to prevent manifest toward leprosy and prevent it 
from spreading. We evaluate the result of 2 years preventive treatment to subclinical leprosy 
in elementary school children using special regiment rifampicin and clarithromycin in Raas 
Island and Nguling, East Java, Indonesia.
Serological surveys for leprosy were conducted and involved a total of 5066 school children, 
who were screened in 2 leprosy endemic locations in East Java. About 302 elementary school 
children [109 from Nguling (Figure 15) and 193 from Raas Island (Figure 16)] were positive 
for sero (+++) with high IgM antiPGL‐1 antibody titer (>3000 U/ml ELISA). Rifampicin 300 mg 
daily with 250 mg clarithromycin daily for 10 days was given as a preventive treatment, con‐
tinued with the same drugs administered intermittently every 2 weeks for 3 months. Every 
year, clinical and serological examination was evaluated.
After 2 years evaluation, none of the children showed any manifestation of leprosy clini‐
cally. IgM antiPGL‐1 antibody level showed to decrease between these 2 years of evaluation 
(Raas Island and Nguling: p = 0.00). The majority of the children (Raas Island 96.46%; Nguling 
94.83%) showed a decrease in IgM antiPGL‐1 antibody level, but some of these children (Raas 
Island 3.54%; Nguling 5.17%) also showed an increased level of IgM antiPGL‐1 antibody. All 
the medications were well tolerated by these children and only a few side effects due to these 
drugs were reported.
Figure 14. Graphic of TNF‐α in 10 patients. Yellow: improving patients; white: dropped out patients; blue: level of 
TNF‐α.
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Chemoprophylaxis for subclinical leprosy in children showed a promising good result after 
2 years of evaluation. Further evaluation will be conducted for the next 3 years ahead. Our 
research about subclinical leprosy in children may support the clinical importance of it in 
exploring the disease transmission and how we can prevent it.
From these three studies, evaluation of resistance for suspected cases, MSM administration 
for refractory cases to steroid and administration of chemoprophylaxis for subclinical leprosy, 
can be implemented on routine leprosy management. Ongoing research is expected to pre‐
vent the onset of leprosy. Study on the impact of chemoprophylaxis in household and neigh‐
bor contact person with a grant from the Netherlands Leprosy Relief is also being carried out 
in collaboration with the Ministry of Health and local government.
Figure 15. Evaluation of IgM antiPGL‐1 in Nguling. Green = decrease; red = increase.
Figure 16. Evaluation of IgM antiPGL‐1 in Raas Island. Green = decrease; red = increase.
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2.3. Mode of the transmission
During this time, it is believed that the only source of transmission is leprosy MB type, but as 
we have not achieved elimination, we begin to think about another source of the transmission.
2.3.1. Strain local study in endemic area using PCR sequencing
Multiple locus variable number of tandem repeat (VNTR) analysis has been proposed as a mean 
of genotyping for tracking leprosy transmission [7]. Many tandem repeats have been reported 
to be polymorphic with the potential as genetic markers to differentiate strains of M. leprae. 
However, depending on the population, the characteristics of polymorphism may vary. We 
measured the copy number of repeat in four genetic markers, which are TTC, AC 8a, AC 9, and 
6–7 (Figures 17–23) in leprosy patients. A number of 23 patients were recruited from outpatient 
clinic in Department of Dermato‐Venereology of Dr Hasan Sadikin Hospital, Bandung. Multiple 
locus VNTR analysis at four loci was applied using total DNA extracts from skin biopsies.
Figure 17. TTC PCR product: lane 1: 100 bp ladder, lane 2: PC, lanes 3–7: samples, lane 8: NC.
Figure 18. AC 8A and AC 9 PCR product: lane 1: PC AC 8a, lanes 2–4: samples, lane 5: NC AC 8a, lane 6: 100 bp ladder, 
lane 7: PC AC 9, lanes 8–10: samples, lane 11: NC.
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As shown in Table 3, there were five samples showing the same copy number of four genetic 
marker: TTC = 15; AC 8a = 10; AC 9 = 10, and 6–7 = 6. Two samples showing the same copy 
Figure 19. PCR product: lane 1: PC, lanes 2,4,5: samples, lane 3: 100 bp ladder, lane 6: NC.
Figure 20. PCR sequencing result: primer TTC.
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number of four genetic marker: TTC = 16; AC 8a = 10; AC 9 = 11, and 6–7 = 6. The multiple 
locus VNTR analysis shows two identical M. leprae VNTR profiles from Bandung. These attri‐
butes support the use of VNTR loci for transmission studies and VNTR analysis can use for 
multicases family study.
Figure 23. PCR sequencing result: primer 6–7.
Figure 22. PCR sequencing result: primer AC 9.
Figure 21. PCR sequencing result: primer AC 8A.
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2.3.2. Environment study and multicase family study using PCR sequencing
East Java is a province in Indonesia that has few endemic areas for leprosy [8]. In order to 
comprehend this increasing incidence of leprosy, molecular typing will make it feasible to 
study geographical distributions of M. leprae. Genotyping analysis was done by using vari‐
able number tandem repeats that found in the rpoT gene which was followed by the recognition 
of the TTC triplet in a region of the M. leprae genome. The aim of this study is to analyze the 
number variation of TTC repeats and their distributions in leprosy endemic areas. Poteran 
Table of VNTR analysis
No TTC AC 8a AC 9 6–7
1 12
2 13 11 6
3 14
4 15 10 10 6
5 15 10 10 6
6 15 10 10 6
7 15 10 10 6
8 15 10 10 6
9 15 10 10 6
10 15 10 10 6
11 16 10 11 6
12 16 7 10
13 16 10 11 6
14 16 10 11 6
15 17 9 6
16 17 8 8 6
17 18
18 21 8 10 8
19 21 8 9 8
20 22
21 23
22 25 8
23 37
Table 3. VNTR analysis in clinical sample from Bandung isolates.
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Island in Madura was chosen for its high prevalence for leprosy and the number has remained 
stable for the last 5 years. Samples were collected and divide into 3 groups: 91 water sources; 
42 nasal swabs of household contact, and 68 skin tissues of leprosy patients. All samples 
were analyzed by using PCR (Figure 24) and the numbers of TTC repeats were confirmed by 
direct sequencing. From all collected samples, 24 isolates from water resources were positive 
(26.4%); 26 nasal swabs were also positive (61.9%); and also 24 skin tissues (35.3%).
Figure 24. TTC PCR product lane 1: 100 bp ladder; lanes 2–5: sample, lane 6: NC, lane 7: PC.
No. of repeats Slit‐skin specimens Nasal swabs Water sources
TTC‐9 0 0 4
TTC‐10 20 10 8
TTC‐11 32 42 36
TTC‐12 4 4 0
TTC‐13 8 4 12
TTC‐14 16 28 32
TTC‐15 0 0 4
TTC‐16 4 0 0
TTC‐17 0 4 0
TTC‐24 4 0 0
TTC‐28 4 0 0
TTC‐40 4 0 0
TTC‐44 0 8 0
TTC‐49 0 0 4
TTC‐60 4 0 0
Total 100% (24 cases) 100%(26 cases) 100% (24 cases)
Table 4. Genotypes TTC frequency (%).
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The copy number of TTC repeats in Talango Island varied from 9 to 60 copies (Table 4). The 
11‐copy TTC genotype was the most frequent in all samples.
The copy number of TTC repeats in Talango Island varied from 10 to 11 copies (Table 5). The 
11‐copy TTC genotype was the most frequent in all samples. There were no differences were 
found statistically in the pattern distribution of TTC repeats between nasal swab of house‐
holds contacts and skin tissues of patients (p = 0.594); skin tissues of leprosy patients and 
water resources (p = 0.441); nasal swab of households contact with water resources (p = 0.906). 
It can be concluded in endemic areas, transmission of M. leprae has strong ties with these three 
aspects: agent, host, and environment.
2.3.3. Mother‐baby transmission in leprosy
Lucio phenomenon is a rare type of reaction in untreated lepromatous leprosy type with 
diffuse infiltrative form, characterized with ulcerative type of skin lesions [9]. In this study, 
a case of 29‐year‐old Indonesian female, 7th month primigravida with lucio leprosy, with‐
out prior treatment using WHO‐multidrug therapy (MDT). Laboratory examinations 
reported bacterial index 6+ and morphological index 7% from slit‐skin smear; histopathol‐
ogy revealed lucio phenomenon; PCR examination found M. leprae DNA on amniotic fluid 
and skin lesion: positive; umbilical cord membrane and umbilical cord: negative (Figure 25). 
AntiPGL‐1 IgM and IgG from patient: 4854 and 1061 U/mL, respectively; from 5‐month‐old 
baby: 5 and 1724 U/mL, respectively; from 1‐year‐old baby: 0 and 3 U/mL, respectively.
Location Family member Relationship TTC repeat
Nasal swab Slit‐skin spec.
House 1 MB patient Husband 10 10
Family contact Wife 11
Family contact Child ‐ a
Suspect leprosy Child ‐ 11
Family contact Mother 10
Family contact Sister in law 11
Family contact Mother in law 10
Family contact Father in law ‐
House 2 
(Neighborhood)
MB patient Child 11 11
Family contact Mother 11
Family contact Father 10
Family contact Child ‐
Family contact Child 11
Table 5. Variation of TTC repeats in multicase family.
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In Table 6, patient’s antiPGL‐1 IgM and IgG titers collected during caesarian section were 
way over the cutoff limit, whereas the antiPGL‐1 IgM and IgG titers from the umbilical 
cord blood were below the limit. Hence, placenta is regarded as a protective barrier against 
fetomaternal transmission of M. leprae. The placenta has multiple innate defense proper‐
ties against pathogens. Only few pathogens can pass through these barriers at low fre‐
quencies. DNA of M. leprae was found in the amniotic fluid. About 5% of babies born from 
Figure 25. PCR examination: 1: skin lesion; 2: amniotic fluid; 3: umbilical cord membrane; 4: umbilical cord; 5: negative 
control; 6: positive control M. leprae Thai53; 7: DNA ladder.
Subject ELISA anti PGL‐1 (U/mL) Cut off (U/mL)
IgM IgG IgM IgG
Patient during the 
caesarian section
4854 1061
Umbilical cord blood 
during the caesarian 
section
0 516
Patient (after 7 
months of therapy)
l912 1505 605 630
Baby (5 month‐old) 5 1724
Baby (1 year‐old) 0 3
Table 6. Results of serological examination using ELISA.
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mothers with active leprosy had self‐limited indeterminate leprosy before 2 years old and 
also antiwill have M. leprae antibodies of class IgA, IgG, and IgM. The presence of IgA and 
IgM antiM. leprae antibodies in the cord blood of newborn babies from mothers with lep‐
rosy might shows an intrauterine immunologic stimulation process that happened due to 
transplacental transmission of M. leprae antibodies. Titers for antiPGL‐1 IgM and IgG were 
reviewed again after the babies reached 5 months old and 1‐year‐old. On assessment, the 
titers were found to drop drastically, especially antiPGL‐1 IgG titer. Based on these facts, 
we assume that passive antibody to M. leprae from the babies had been acquired from their 
mothers’ blood and transmitted through the umbilical cord blood as shown by the presence 
of antiPGL‐1 IgG antibody.
Studies in genotyping of patients and contact person proved that genotyping is not always 
appropriate; there is still the possibility of environmental transmission source. From these three 
studies above, there can be further potential research on transmission of leprosy from nonhu‐
man sources. In the transmission pattern from mother to baby, it shows the importance of the 
role of placenta as a barrier, therefore, the health of the expecting mother needs to be optimized 
so as to prevent fetomaternal transmission and to treat the mother as early as possible and 
closely monitored the baby during incubation phase.
3. Conclusions
Dissemination of an integrated translational research above is done through aspects: edu‐
cation: lectures, case discussions, bed side teaching, and writing research‐based textbook 
for medical students, undergraduates, postgraduates, and dermatology and venereology 
residency program. Besides, presentations are done at local and international scientific meet‐
ings as well as publication of journals. Research: an integrated translational research is a 
continuous activity with the ultimate goal to eliminate leprosy in Indonesia. Community 
services: improving services and counseling at social events as well as when we are doing 
research in endemic pockets area. Besides, counseling is also done through electronic media. 
Community services can be done in practice of the research results of what they learned 
through lectures and case discussions in accordance with the level of competence they need 
to accomplish.
Various educational activities, research, and community service above increase knowledge 
about leprosy with the ultimate goal of achieving elimination through improvements in the 
field of preventive, curative, promotive, and rehabilitative. Here, the role of educational insti‐
tutions is very important in helping to resolve the national problem. In the future, we hope 
more collaboration research of diagnosis, management, and mode of transmission will be 
conducted to overcome the problem of leprosy include early detection, management evalua‐
tion, and termination of the transmission chain. Integrated translational research is important 
to be done to resolve leprosy problems both in the community and clinics during the process 
of medical education.
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